EDITOR'S NOTE
Is overall survival the only important endpoint in Phase III randomized clinical trials?
Neil Love, MD

FACULTY INTERVIEWS
Bruce D Cheson, MD
Head of Hematology
Director of Hematology Research
Georgetown University Hospital
Lombardi Comprehensive Cancer Center
Washington, DC
- Select publications

Myron S Czuczman, MD
Head, Lymphoma/Myeloma Service
Roswell Park Cancer Institute
Associate Professor of Medicine
School of Medicine and Biomedical Sciences
State University of New York at Buffalo
Buffalo, New York
- Select publications

James O Armitage, MD
Joe Shapiro Professor of Medicine
Section of Oncology/Hematology
University of Nebraska Medical Center
Omaha, Nebraska
- Select publications

Faculty Disclosures

A CME Audio Series and Activity

Editor's office